ER

Expert Review of Neurotherapeutics

Expert Review of Neurotherapeutics is a MEDLINE-indexed international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on the use of drugs and medicines in clinical neurology and neuropsychiatry. The journal focuses on disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines, and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's, and it does not publish case reports or case series.

Looking to publish in Expert Review of Neurotherapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Clinical Neurology, Pharmacology & Pharmacy
Impact Factor 3.4
Quartile Q2
Open Access Type Hybrid
ISSN 1473-7175
eISSN 1744-8360
Invitation Only No
Cost Range Institutional subscription pricing listed as USD 6,169.00 for online only and USD 9,032.00 for print and online; personal subscription pricing available on request.

Submission Instructions

Expert Review of Neurotherapeutics accepts the following article types. Click on an article type to view submission instructions.

Original Research

Cover Letter Original Research submissions must include a covering letter. Cover letter must provide the corresponding author’s full contact details, state that the work is original and not under simultaneous submission, confirm all authors have read and approved the manuscript and meet ICMJE conditions, identify the body granting ethical approval, disclose financial or other declarable relationships or explicitly state none, and mention any prior abstract, poster, or oral presentation.
Abstract Original Research articles must include a structured abstract on the second page. Abstract must be no more than 200 words. Abstract must be structured. Abstract must use the headings Background, Research design and methods, Results, and Conclusions.
Manuscript Body of the article must include the sections Introduction, Patients and methods, Results, Discussion, and Conclusions. Manuscript must include 4–6 keywords in alphabetical order, an Author contributions section, an Acknowledgements section, and an AI-use acknowledgement where applicable.
References References must use NLM style. References must be numbered consecutively in order of first mention, cited in square brackets, and listed in numerical order at the end of the article.
Figures & Tables A maximum of five figures and five tables is permitted. Tables must be supplied as editable files.
Reformat to Expert Review of Neurotherapeutics using Livewrite Premium

Review Article

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must not exceed 200 words. Abstract must be structured. Abstract must include the headings Introduction, Areas covered, and Expert Opinion/Commentary in that order.
Manuscript Manuscript must include 5–8 keywords and a statement acknowledging any use of AI.
References References must use NLM style. References must be numbered consecutively in order of first mention and cited in square brackets, with the reference list presented in numerical order.
Figures & Tables A maximum of five figures and five tables is permitted. Tables must be supplied as editable files.
Reformat to Expert Review of Neurotherapeutics using Livewrite Premium

Systematic Reviews

Cover Letter A separate cover sheet must include all authors’ names, affiliations, addresses, academic qualifications, job titles, and the corresponding author’s telephone number and email address.
Abstract A structured abstract is required. Abstract must not exceed 200 words. Abstract must be structured. Abstract must use the headings Introduction, Methods, Results, and Conclusions.
Manuscript Article body must include the sections Introduction, Methods, Results, and Discussion. Manuscript must include 4 to 10 keywords in alphabetical order, funding information, potential conflicts of interest, an author contribution statement, registration details including registration numbers where applicable, and acknowledgment of AI use.
References Around 100 references are suggested for a full-length review. References must use NLM style. References must be numbered consecutively in order of first mention and important references must be highlighted with one or two asterisks plus a brief annotation.
Figures & Tables Up to 5 figures and up to 5 tables are permitted. Permission documentation for previously published figures must be uploaded alongside the manuscript. Tables or plots must be used to support the presentation of results.
Reformat to Expert Review of Neurotherapeutics using Livewrite Premium

Meta-Analyses

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must not exceed 200 words. Abstract must be structured. Abstract must use the headings Introduction, Methods, Results, and Conclusions.
Manuscript Article body must include the sections Introduction, Methods, Results, and Discussion. Manuscript must include 4 to 10 keywords in alphabetical order, funding information, potential conflicts of interest, an author contribution statement, registration details including registration numbers where applicable, and an AI-use acknowledgment if AI was used.
References Around 100 references are suggested for a full-length review. References must use NLM style. References must be numbered consecutively in order of first mention, cited in square brackets, listed in numerical order, and important references must be marked with one or two asterisks plus a brief annotation.
Figures & Tables Up to 5 figures and up to 5 tables are permitted. Permission documentation for previously published figures must be uploaded alongside the manuscript. Tables or plots must be used to support the presentation of results.
Reformat to Expert Review of Neurotherapeutics using Livewrite Premium

Clinical Trial Report

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must include the trial registration number.
Manuscript Manuscript must include full trial registration details in the Methods section. Manuscript must include 5-8 keywords and a statement acknowledging any use of AI.
References References must use NLM style. References must be numbered consecutively in order of first citation and presented in numerical order using square-bracketed numbers.
Figures & Tables A maximum of five figures and five tables is permitted.
Reformat to Expert Review of Neurotherapeutics using Livewrite Premium

Drug Profile

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must not exceed 200 words. Abstract must be structured. Abstract must include the headings Introduction, Areas covered, and Expert Opinion/Commentary in that order.
Manuscript Manuscript must include 5–8 keywords and acknowledge any use of AI.
References References must use NLM style. References must be numbered consecutively in order of first mention and cited in square brackets, with the reference list presented in numerical order.
Figures & Tables A maximum of five figures and five tables is permitted. Tables must be supplied as editable files.
Reformat to Expert Review of Neurotherapeutics using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Include 5–8 keywords and an AI use statement where applicable.
References References must use NLM style. References must be numbered consecutively in order of first mention and cited in square brackets, with the reference list presented in numerical order.
Figures & Tables A maximum of five figures and five tables is permitted.
Reformat to Expert Review of Neurotherapeutics using Livewrite Premium

Recent Publications

Understanding the genetic risk of schizophrenia

Sophie L. Chick, Elliott Rees

10.1080/14737175.2026.2702634
View Publication

Innovation is not enough: lessons from lasmiditan for real-world effectiveness in acute migraine therapy

Simona Guerzoni, Lanfranco Pellesi

10.1080/14737175.2026.2701917
View Publication

Can the integration of blood-based biomarkers into Alzheimer’s disease diagnosis revolutionize the field?

Lorenzo Gaetani, Giovanna Nardi, Lucilla Parnetti

10.1080/14737175.2026.2700246
View Publication

An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache

Amy Gimson, Nasia Christou, Fiona Greenwood, Stefania Maniataki, Peter J. Goadsby

10.1080/14737175.2026.2688942
View Publication

Multiomics and proteomic insights into Alzheimer’s disease biology in down syndrome

Mitchell Marta-Ariza, Thomas Wisniewski

10.1080/14737175.2026.2695187
View Publication

Frequently asked questions

How long does it take to publish?

Accepted Author Version published online in 3 days after acceptance provided the copyright form has been received. Accelerated Publication Plus offers a final decision in as little as 3 weeks from submission, with peer review in approximately 2 weeks, first proofs within 5 working days, and online publication usually 1–2 weeks after acceptance. Accelerated Publication offers a final decision in as little as 9 weeks from submission, with peer review within approximately 4 weeks, first proofs within 5 working days, and online publication usually 2–3 weeks after acceptance. Corrections to proofs should be returned within 48 hours.

Reformat to Expert Review of Neurotherapeutics using Livewrite Premium

Is a cover letter required?

A covering letter is required. Complete submissions must include a covering letter and a Disclosure Form. The letter should provide corresponding author contact details, confirm originality and exclusive submission, confirm author approval and ICMJE conditions, state ethical approval, and disclose financial relationships or declare that none exist.

Reformat to Expert Review of Neurotherapeutics using Livewrite Premium

What are the publication costs?

Institutional subscription pricing is USD 6,169.00 for online only and USD 9,032.00 for print and online. Personal subscription pricing is available on request.

Reformat to Expert Review of Neurotherapeutics using Livewrite Premium

Research Topics

Neurological disorders and treatments Epilepsy research and treatment Parkinson's Disease Mechanisms and Treatments Multiple Sclerosis Research Studies Migraine and Headache Studies Bipolar Disorder and Treatment Pharmacological Effects and Toxicity Studies Schizophrenia research and treatment Alzheimer's disease research and treatments Glioma Diagnosis and Treatment Attention Deficit Hyperactivity Disorder Neuroscience and Neuropharmacology Research Treatment of Major Depression Acute Ischemic Stroke Management Peripheral Neuropathies and Disorders Botulinum Toxin and Related Neurological Disorders Dementia and Cognitive Impairment Research Trigeminal Neuralgia and Treatments Pain Mechanisms and Treatments Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Genetic Neurodegenerative Diseases Sympathectomy and Hyperhidrosis Treatments Child and Adolescent Psychosocial and Emotional Development Functional Brain Connectivity Studies Science, Research, and Medicine

Related Journals

Ne
Neuropharmacology Elsevier BV
BP
Brain Pathology WILEY
Al
Alcohol Elsevier BV
Sp
Spine LIPPINCOTT WILLIAMS & WILKINS
SP
Saudi Pharmaceutical Journal Elsevier BV
TA
Therapeutic Advances in Psychopharmacology SAGE Publishing